Study By Step - Schools details and Study Materials

Stocks »Recommendations »Aurobindo Pharma Ltd

Accumulate Aurobindo Pharma Ltd for the Target Price of 1065 - Prabhudas Lilladher

Submitted By Nimmy Sunil on 20 November 2023

Prabhudas Lilladher has given the Accumulate recommendation for Aurobindo Pharma Ltd at the target price of 1065.

Recommendation Details

Company Name: Aurobindo Pharma Ltd

Recommendation: Accumulate

Recommended By: Prabhudas Lilladher

Recommended on: November 11 2023

Targtet Price: 1065

Stock Status on 20 November 2023 (NSE)

Stock Price : 1007.35

52 Week Low Price: 397.20

52 Week High Price: 1024.95

Stock trend is Bullish as per the status on 20 November 2023. Stock Price details are taken on 20 November 2023 and can be the price of same day or previous day.

Other facts you may consider

Target price given is away from current share price by Rs 57.65 per share which is 5.72 % higher than the current price.

Stock is trading at 60.57% (Rs.610.15) higher than the 52 week low price.

Current share price is 1.75% (Rs.17.6) lower than the 52 week high price.

Share Target price is higher than the 52 week high price.


Aurobindo Pharma Ltd stock price,Aurobindo Pharma Ltd target price,Aurobindo Pharma Ltd buy/sell/hold,Aurobindo Pharma Ltd trend,Aurobindo Pharma Ltd 52 week low and 52 week high price,Aurobindo Pharma Ltd recommendation, Aurobindo Pharma Ltd buy/sell recommendations - Prabhudas Lilladher is Bullish on Aurobindo Pharma Ltd and has given Accumulate recommendations with the target of 1065


Stock prices are subject to fluctuate as per global market situations and many other factors. Stock market investment is considered as a high risk investment method. Our recommendations are our own opinions. We ( don't give any warranties of the information provided and don't take any responsibility for the losses or profits. This is just for your reference. We always suggest that you should check multiple sources and check all information before investing. We try to provide accurate information as much as possible, but there can be manual mistakes.


Home Privacy Policy Terms of use Disclaimer Contact us

©Copy Right 2023